Clinical Trials Browser

Phase 1 × CLR1404 × Plasma cell × Clear all

NCT02278315 2023-02-22

Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Completed

Multiple Myeloma